BACKGROUND:Although the pathogenesis of Hodgkin disease (HD) remains unknown, the results of epidemiologic studies suggest that heritable factors are important in terms of susceptibility. Polymorphisms in DNA repair genes may contribute to individual susceptibility for development of different cancers. However, to the authors' knowledge, few studies to date have investigated the role of such polymorphisms as risk factors for development of HD.METHODS:The authors evaluated the relation between polymorphisms in 3 nucleotide excision repair pathway genes (XPD [Lys751Gln], XPC [Lys939Gln], and XPG [Asp1104His]), the base excision repair XRCC1 (Arg399Gln), and double‐strand break repair XRCC3 (Thr241Met) in a population of 200 HD cases and 220 matched controls. Variants were investigated independently and in combination; odd ratios (OR) were calculated.RESULTS:A positive association was found for XRCC1 gene polymorphism Arg399Gln (OR, 1.77; 95% confidence interval [95% CI], 1.16‐2.71) and risk of HD. The combined analysis demonstrated that XRCC1/XRCC3 and XRCC1/XPC polymorphisms were associated with a significant increase in HD risk. XRCC1 Arg/Arg and XRCC3 Thr/Met genotypes combined were associated with an OR of 2.38 (95% CI, 1.24‐4.55). The XRCC1 Arg/Gln and XRCC3 Thr/Thr, Thr/Met, and Met/Met genotypes had ORs of 1.88 (95% CI, 1.02‐4.10), 1.97 (95% CI, 1.05‐3.73), and 4.13 (95% CI, 1.50‐11.33), respectively. XRCC1 Gln/Gln and XRCC3 Thr/Thr variant led to a significant increase in risk, with ORs of 3.00 (95% CI, 1.15‐7.80). Similarly, XRCC1 Arg/Gln together with XPC Lys/Lys was found to significantly increase the risk of HD (OR, 2.14; 95% CI, 1.09‐4.23).CONCLUSIONS:These data suggest that genetic polymorphisms in DNA repair genes may modify the risk of HD, especially when interactions between the pathways are considered. Cancer 2009. © 2009 American Cancer Society.

DNA repair variants may play a potentially important role in an individual’s susceptibility to developing cancer. Numerous studies have reported the association between genetic single nucleotide polymorphisms (SNPs) in DNA repair genes and different types of hematologic cancers. However, to date, the effects of such SNPs on modulating Hodgkin Lymphoma (HL) risk have not yet been investigated. We hypothesized that gene-gene interaction between candidate genes in Direct Reversal, Nucleotide excision repair (NER), Base excision repair (BER) and Double strand break (DSB) pathways may contribute to susceptibility to HL. To test this hypothesis, we conducted a study on 200 HL cases and 220 controls to assess associations between HL risk and 21 functional SNPs in DNA repair genes. We evaluated potential gene-gene interactions and the association of multiple polymorphisms in a chromosome region using a multi-analytic strategy combining logistic regression, multi-factor dimensionality reduction and classification and regression tree approaches. We observed that, in combination, allelic variants in the XPC Ala499Val, NBN Glu185Gln, XRCC3 Thr241Me, XRCC1 Arg194Trp and XRCC1 399Gln polymorphisms modify the risk for developing HL. Moreover, the cumulative genetic risk score revealed a significant trend where the risk for developing HL increases as the number of adverse alleles in BER and DSB genes increase. These findings suggest that DNA repair variants in BER and DSB pathways may play an important role in the development of HL.

Introducción. El glifosato es un herbicida de amplio espectro, no selectivo, utilizado para eliminar malezas indeseables en ambientes agrícolas y forestales. La acción herbicida corresponde a la inhibición de la biosíntesis de aminoácidos aromáticos en las plantas. Al no ser este mecanismo compartido por los seres humanos es considerado como de bajo riesgo para la salud de los mismos. Sin embargo, investigaciones recientes indican que puede alterar otros procesos celulares en animales lo que puede presentar un factor de riesgo a nivel ambiental y de salud en las zonas donde se emplea este herbicida. Objetivo. El objetivo del presente estudio fue evaluar la citotoxicidad y la genotoxicidad del glifosato en células humanas normales (GM38) y en células humanas de fibrosarcoma (HT1080). Materiales y métodos. La citotoxicidad aguda y crónica se determinó al exponer las células en cultivo a diferentes concentraciones de glifosato, y se analizó la viabilidad celular con cristal violeta y colorante de exclusión azul de tripano, respectivamente. La genotoxicidad se determinó por medio del ensayo del cometa y los datos se analizaron usando la prueba de Dunnet. Resultados. En la citotoxicidad crónica las células GM38 y las HT1080 presentaron un efecto dependiente de la dosis después del tratamiento con glifosato en concentraciones de 5,2 a 8,5 mM y 0,9 a 3,0 mM, respectivamente. En la citotoxicidad aguda, las células GM38 y las HT1080 expuestas a un rango de concentraciones de 4,0 a 7,0 mM, 4,5 a 5,75 mM y 4,0 a 7,0 mM, respectivamente, presentaron una viabilidad mayor al 80%. Se evidenció daño en el ADN después del tratamiento con glifosato en concentraciones de 4,0 a 6,5 mM para las células GM38 y de 4,75 a 5,75 mM para las células HT1080. Conclusiones. Se sugiere que el mecanismo de acción del glifosato no se limita únicamente a las plantas sino que puede alterar la estructura del ADN en otros tipos de células como son las de los mamíferos.Palabras clave: herbicidas, citotoxicidad, genotoxicidad, ensayo cometa. Cytotoxicity and genotoxicity of human cells exposed in vitro to glyphosateIntroduction. Glyphosate is a broad-spectrum non-selective herbicide, used to eliminate unwanted weeds in agricultural and forest settings. Herbicide action is achieved through inhibition of aromatic amino acid biosynthesis in plant cells. Since this is not a conserved mechanism between human and plant cells, glyphosate is considered to be a low health risk substance for humans. However, the occurrence of possible harmful side effects of glyphosate use is not well documented and controversial. Toxicity and genotoxicity studies indicate that glyphosate is not harmful, although several investigations suggest that it can alter various cellular processes in animals. Therfore this has potential as a health and environmental risk factor in areas where glyphosate is widely used.Objectives. The present study evaluated glyphosate cytotoxic and genotoxic effects in normal human cells (GM38) and human fibrosarcoma (HT1080) cells. Materials and method...

Genetic instability plays a crucial role in cancer development. The genetic stability of the cell as well as DNA methylation status could be modulated by folate levels. Several studies suggested associations between polymorphisms in folate genes and alterations in protein expression and variations in serum levels of the folate. The objective of this study was to investigate the effect of folate pathway polymorphisms on modulating genetic instability and lung cancer risk. Genotyping of 5 SNPs in folate pathway genes and cytokinesis-blocked micronucleus cytome assay analysis (to determine the genetic instability at baseline and following NNK treatment) was conducted on 180 lung cancer cases and 180 age-, gender-, and smoking-matched controls. Our results showed that individually, folate pathway SNPs were not associated with cytogenetic damage or lung cancer risk. However, in a polygenic disease such as lung cancer, gene-gene interactions are expected to play an important role in determining the phenotypic variability of the diseases. We observed that interactions between MTHFR677, MTHFR1298, and SHMT polymorphisms may have a significant impact on genetic instability in lung cancer patients. With regard to cytogenetic alterations, our results showed that lymphocytes from lung cancer patients exposed to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] had considerably increased frequency of cytogenetic damage in presence of MTHFR 677, MTHFR 1298, and SHMT allelic variants. These findings support the notion that significant interactions may potentially modulate the lung cancer susceptibility and alter the overall the repair abilities of lung cancer patients when exposed to tobacco carcinogens such as NNK.

Inflammation is a critical component of cancer development. The clinical and pathological features of Hodgkin disease (HD) reflect an abnormal immunity that results from cytokines secreted by Reed-Sternberg cells and the surrounding tumor. Numerous studies have reported the association between genetic polymorphisms in cytokine genes and the susceptibility to different hematologic cancers. However, the effects of such SNPs on modulating HD risk have not yet been investigated. We hypothesized that gene-gene interactions between candidate genes in the anti- and pro-inflammatory pathways carrying suspicious polymorphisms may contribute to susceptibility to HD. To test this hypothesis, we conducted a study on 200 HD cases and 220 controls to assess associations between HD risk and 38 functional SNPs in inflammatory genes. We evaluated potential gene-gene interactions using a multi-analytic strategy combining logistic regression, multi-factor dimensionality reduction, and classification and regression tree (CART) approaches. We observed that, in combination, allelic variants in the COX2, IL18, ILR4, and IL10 genes modify the risk for developing HD. Moreover, the cumulative genetic risk score (CGRS) revealed a significant trend where the risk for developing HD increases as the number of adverse alleles in the cytokine genes increase. These findings support the notion that epigenetic-interactions between these cytokines may influence pathogenesis of HD modulating the proliferation of regulatory T cells. In this way, the innate and adaptative immune responses may be altered and defy their usual functions in the host anti-tumor response. Our study is the first to report the association between polymorphisms in inflammation genes and HD susceptibility risk.